Boon Industries, Inc.

Boon Industries, Inc., a bioscience company, develops chemical solutions for the agricultural, food and beverage, hospitality, and medical industries in the United States and internationally. The company primarily offers DiOx+, an activated chlorine dioxide disinfectant sterilizer that kills harmful pathogens without dangerous toxic exposure to the user or the environment. It also manufactures customized white label products, which includes tinctures of liquid nutritional supplements that utilize nano-emulsification to suspend particles in a solution for the food and beverage industry; and provides modified shipping containers outfitted for agricultural purposes. The company is based in Grass Valley, California.

Boon Industries, Inc. trades as BNOW on OTC. The company is classified in Basic Materials / Chemicals and reports in USD.

The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $34,434 of revenue and -$5.35M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Boon Industries, Inc. can be compared against peers such as AfriTin Mining Limited, Avantium N.V., Badger State Ethanol, LLC, Condor Gold Plc, Gowest Gold Ltd., Highwater Ethanol, LLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $73.42M, beta of 2.44, and return on equity of +7.7%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

BNOW currently shows total debt of $2.64M and beta of 2.44. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.boonindustries.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.